[Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. / Erratum für: Das klinische Ergebnis eines Therapiewechsels von Ranibizumab und/oder Bevacizumab zu Aflibercept bei neovaskulärer altersabhängiger Makuladegeneration (AMD).
Klin Monbl Augenheilkd
; 233(8): e3, 2016 08.
Article
em De
| MEDLINE
| ID: mdl-27599047
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
De
Ano de publicação:
2016
Tipo de documento:
Article